FI915841A - Bifenylylfoereningar. - Google Patents

Bifenylylfoereningar. Download PDF

Info

Publication number
FI915841A
FI915841A FI915841A FI915841A FI915841A FI 915841 A FI915841 A FI 915841A FI 915841 A FI915841 A FI 915841A FI 915841 A FI915841 A FI 915841A FI 915841 A FI915841 A FI 915841A
Authority
FI
Finland
Prior art keywords
bifenylylfoereningar
Prior art date
Application number
FI915841A
Other languages
English (en)
Finnish (fi)
Other versions
FI915841A0 (fi
Inventor
Tibur Schmidlin
Franz Ostermayer
Peter Buehlmayer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI915841A0 publication Critical patent/FI915841A0/fi
Publication of FI915841A publication Critical patent/FI915841A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI915841A 1990-12-14 1991-12-11 Bifenylylfoereningar. FI915841A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH396590 1990-12-14

Publications (2)

Publication Number Publication Date
FI915841A0 FI915841A0 (fi) 1991-12-11
FI915841A true FI915841A (fi) 1992-06-15

Family

ID=4267265

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915841A FI915841A (fi) 1990-12-14 1991-12-11 Bifenylylfoereningar.

Country Status (14)

Country Link
US (1) US5369110A (pt)
EP (1) EP0490820A3 (pt)
JP (1) JPH04300859A (pt)
KR (1) KR920012051A (pt)
AU (1) AU657498B2 (pt)
CA (1) CA2057511A1 (pt)
FI (1) FI915841A (pt)
HU (1) HUT59660A (pt)
IE (1) IE914358A1 (pt)
IL (1) IL100267A0 (pt)
MX (1) MX9102500A (pt)
NO (1) NO914926L (pt)
PT (1) PT99777B (pt)
ZA (1) ZA919837B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59208448D1 (de) * 1991-08-15 1997-06-12 Ciba Geigy Ag N-Acyl-N-Heterocyclyl- oder Naphthylalkyl-Aminosäuren als Angiotensin II Antagonisten
US5312820A (en) * 1992-07-17 1994-05-17 Merck & Co., Inc. Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
US6307090B1 (en) 1999-01-22 2001-10-23 The United States Of America As Represented By The Department Of Health And Human Services Acylated oligopeptide derivatives having cell signal inhibiting activity
EP1163262B1 (en) * 1999-03-23 2011-05-11 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Phenylalanine derivatives
US7226991B1 (en) * 1999-03-23 2007-06-05 United States Of America, Represented By The Secretary, Department Of Health And Human Services Phenylalanine derivatives
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
EP1223959B1 (en) 1999-10-22 2007-05-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Inhibition of cell motility and angiogenesis by inhibitors of the grb2 sh2-domain
US7871981B2 (en) * 1999-10-22 2011-01-18 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of cell motility, angiogenesis, and metastasis
EP1383792A2 (en) * 2000-08-22 2004-01-28 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Sh2 domain binding inhibitors
US7425537B2 (en) * 2000-08-22 2008-09-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services SH2 domain binding inhibitors
US20040138104A1 (en) * 2003-01-14 2004-07-15 The Government Of The United States Of America Represented By The Secretary, Peptides
US20050119163A1 (en) * 2003-09-18 2005-06-02 The Government Of The United States Of America, As Represented By The Secretary, SH2 domain binding inhibitors
DE102004060542A1 (de) 2004-12-16 2006-07-06 Sanofi-Aventis Deutschland Gmbh Hydroxybiphenyl-Carbonsäuren und Derivate, Verfahren zu deren Herstellung und deren Verwendung
DK2170930T3 (da) 2007-06-04 2012-11-05 Synergy Pharmaceuticals Inc Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9522873B2 (en) 2011-08-05 2016-12-20 Dongguk University Industry-Academic Cooperation Foundation Biphenyl derivative, pharmaceutically acceptable salt thereof, and methods for preventing or treating inflammatory diseases or autoimmune diseases
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
KR102272746B1 (ko) 2013-06-05 2021-07-08 보슈 헬스 아일랜드 리미티드 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
GB202014589D0 (en) * 2020-09-16 2020-10-28 Ucl Business Ltd Agents for use in the treatment of amyloidosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
IL96019A0 (en) * 1989-10-31 1991-07-18 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DE122007000050I1 (de) * 1990-02-19 2007-11-08 Novartis Ag Acylverbindungen
FR2677016A1 (fr) * 1991-05-31 1992-12-04 Union Pharma Scient Appl Nouveaux derives d'amide antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
AU8831891A (en) 1992-06-18
IL100267A0 (en) 1992-09-06
PT99777B (pt) 1999-05-31
HU913952D0 (en) 1992-02-28
NO914926D0 (no) 1991-12-13
IE914358A1 (en) 1992-06-17
AU657498B2 (en) 1995-03-16
MX9102500A (es) 1992-06-01
HUT59660A (en) 1992-06-29
CA2057511A1 (en) 1992-06-15
PT99777A (pt) 1992-12-31
US5369110A (en) 1994-11-29
ZA919837B (en) 1992-09-30
NO914926L (no) 1992-06-15
EP0490820A2 (de) 1992-06-17
JPH04300859A (ja) 1992-10-23
KR920012051A (ko) 1992-07-25
EP0490820A3 (en) 1992-10-28
FI915841A0 (fi) 1991-12-11

Similar Documents

Publication Publication Date Title
FI911037A (fi) Inhalationsanordning.
FI915213A0 (fi) Vaermefoerseglingsbar foerpackningsfolie.
FI915214A0 (fi) Vaermefoerseglingsbar foerpackningsfolie.
FI910830A (fi) Dubbelviraformare.
FI911942A0 (fi) Kolhydratderivat innehaollande en trisackaridenhet.
FI915841A0 (fi) Bifenylylfoereningar.
FI910647A (fi) Foerbaettrad kakaofermentation.
FI912757A0 (fi) Fladderdaempande luftspaltfolier.
FI911782A (fi) Linjerasterstorlek reglerande krets.
FI910493A (fi) Spaerrbom.
FI900436A (fi) Foerbraenningsanlaeggning.
FI914333A0 (fi) Varukaerra.
FI904009A (fi) Svaengarm.
FI901257A (fi) Maetcell.
FI901498A0 (fi) Axelsystemkonstruktion foer nyttofordon.
FI913483A (fi) Naetbalk.
FI911328A0 (fi) Povtagningsanordning.
FI902288A (fi) Provtagningsapparat.
FI910502A0 (fi) Paose.
FI904272A (fi) Lyftapparat.
FI904732A (fi) Regelanordning.
FI914018A0 (fi) Foerbaettrade gemfibrozilkompositioner.
FI902556A (fi) Lastbrygga.
FI903520A0 (fi) Indirekt stroemmaetningskrets.
FI911140A (fi) Komponentevalueringssystem.

Legal Events

Date Code Title Description
FD Application lapsed